Cargando…

Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial

IMPORTANCE: The benefit of endovascular stroke therapy (EVT) in large vessel occlusion (LVO) ischemic stroke is highly time dependent. Process improvements to accelerate in-hospital workflows are critical. OBJECTIVE: To determine whether automated computed tomography (CT) angiogram interpretation co...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Gutierrez, Juan Carlos, Kim, Youngran, Salazar-Marioni, Sergio, Tariq, Muhammad Bilal, Abdelkhaleq, Rania, Niktabe, Arash, Ballekere, Anjan N., Iyyangar, Ananya S., Le, Mai, Azeem, Hussain, Miller, Charles C., Tyson, Jon E., Shaw, Sandi, Smith, Peri, Cowan, Mallory, Gonzales, Isabel, McCullough, Louise D., Barreto, Andrew D., Giancardo, Luca, Sheth, Sunil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507590/
https://www.ncbi.nlm.nih.gov/pubmed/37721738
http://dx.doi.org/10.1001/jamaneurol.2023.3206
_version_ 1785107351293919232
author Martinez-Gutierrez, Juan Carlos
Kim, Youngran
Salazar-Marioni, Sergio
Tariq, Muhammad Bilal
Abdelkhaleq, Rania
Niktabe, Arash
Ballekere, Anjan N.
Iyyangar, Ananya S.
Le, Mai
Azeem, Hussain
Miller, Charles C.
Tyson, Jon E.
Shaw, Sandi
Smith, Peri
Cowan, Mallory
Gonzales, Isabel
McCullough, Louise D.
Barreto, Andrew D.
Giancardo, Luca
Sheth, Sunil A.
author_facet Martinez-Gutierrez, Juan Carlos
Kim, Youngran
Salazar-Marioni, Sergio
Tariq, Muhammad Bilal
Abdelkhaleq, Rania
Niktabe, Arash
Ballekere, Anjan N.
Iyyangar, Ananya S.
Le, Mai
Azeem, Hussain
Miller, Charles C.
Tyson, Jon E.
Shaw, Sandi
Smith, Peri
Cowan, Mallory
Gonzales, Isabel
McCullough, Louise D.
Barreto, Andrew D.
Giancardo, Luca
Sheth, Sunil A.
author_sort Martinez-Gutierrez, Juan Carlos
collection PubMed
description IMPORTANCE: The benefit of endovascular stroke therapy (EVT) in large vessel occlusion (LVO) ischemic stroke is highly time dependent. Process improvements to accelerate in-hospital workflows are critical. OBJECTIVE: To determine whether automated computed tomography (CT) angiogram interpretation coupled with secure group messaging can improve in-hospital EVT workflows. DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized stepped-wedge clinical trial took place from January 1, 2021, through February 27, 2022, at 4 comprehensive stroke centers (CSCs) in the greater Houston, Texas, area. All 443 participants with LVO stroke who presented through the emergency department were treated with EVT at the 4 CSCs. Exclusion criteria included patients presenting as transfers from an outside hospital (n = 158), in-hospital stroke (n = 39), and patients treated with EVT through randomization in a large core clinical trial (n = 3). INTERVENTION: Artificial intelligence (AI)–enabled automated LVO detection from CT angiogram coupled with secure messaging was activated at the 4 CSCs in a random-stepped fashion. Once activated, clinicians and radiologists received real-time alerts to their mobile phones notifying them of possible LVO within minutes of CT imaging completion. MAIN OUTCOMES AND MEASURES: Primary outcome was the effect of AI-enabled LVO detection on door-to-groin (DTG) time and was measured using a mixed-effects linear regression model, which included a random effect for cluster (CSC) and a fixed effect for exposure status (pre-AI vs post-AI). Secondary outcomes included time from hospital arrival to intravenous tissue plasminogen activator (IV tPA) bolus in eligible patients, time from initiation of CT scan to start of EVT, and hospital length of stay. In exploratory analysis, the study team evaluated the impact of AI implementation on 90-day modified Rankin Scale disability outcomes. RESULTS: Among 243 patients who met inclusion criteria, 140 were treated during the unexposed period and 103 during the exposed period. Median age for the complete cohort was 70 (IQR, 58-79) years and 122 were female (50%). Median National Institutes of Health Stroke Scale score at presentation was 17 (IQR, 11-22) and the median DTG preexposure was 100 (IQR, 81-116) minutes. In mixed-effects linear regression, implementation of the AI algorithm was associated with a reduction in DTG time by 11.2 minutes (95% CI, −18.22 to −4.2). Time from CT scan initiation to EVT start fell by 9.8 minutes (95% CI, −16.9 to −2.6). There were no differences in IV tPA treatment times nor hospital length of stay. In multivariable logistic regression adjusted for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early CT Score, there was no difference in likelihood of functional independence (modified Rankin Scale score, 0-2; odds ratio, 1.3; 95% CI, 0.42-4.0). CONCLUSIONS AND RELEVANCE: Automated LVO detection coupled with secure mobile phone application-based communication improved in-hospital acute ischemic stroke workflows. Software implementation was associated with clinically meaningful reductions in EVT treatment times. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05838456
format Online
Article
Text
id pubmed-10507590
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-105075902023-09-20 Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial Martinez-Gutierrez, Juan Carlos Kim, Youngran Salazar-Marioni, Sergio Tariq, Muhammad Bilal Abdelkhaleq, Rania Niktabe, Arash Ballekere, Anjan N. Iyyangar, Ananya S. Le, Mai Azeem, Hussain Miller, Charles C. Tyson, Jon E. Shaw, Sandi Smith, Peri Cowan, Mallory Gonzales, Isabel McCullough, Louise D. Barreto, Andrew D. Giancardo, Luca Sheth, Sunil A. JAMA Neurol Original Investigation IMPORTANCE: The benefit of endovascular stroke therapy (EVT) in large vessel occlusion (LVO) ischemic stroke is highly time dependent. Process improvements to accelerate in-hospital workflows are critical. OBJECTIVE: To determine whether automated computed tomography (CT) angiogram interpretation coupled with secure group messaging can improve in-hospital EVT workflows. DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized stepped-wedge clinical trial took place from January 1, 2021, through February 27, 2022, at 4 comprehensive stroke centers (CSCs) in the greater Houston, Texas, area. All 443 participants with LVO stroke who presented through the emergency department were treated with EVT at the 4 CSCs. Exclusion criteria included patients presenting as transfers from an outside hospital (n = 158), in-hospital stroke (n = 39), and patients treated with EVT through randomization in a large core clinical trial (n = 3). INTERVENTION: Artificial intelligence (AI)–enabled automated LVO detection from CT angiogram coupled with secure messaging was activated at the 4 CSCs in a random-stepped fashion. Once activated, clinicians and radiologists received real-time alerts to their mobile phones notifying them of possible LVO within minutes of CT imaging completion. MAIN OUTCOMES AND MEASURES: Primary outcome was the effect of AI-enabled LVO detection on door-to-groin (DTG) time and was measured using a mixed-effects linear regression model, which included a random effect for cluster (CSC) and a fixed effect for exposure status (pre-AI vs post-AI). Secondary outcomes included time from hospital arrival to intravenous tissue plasminogen activator (IV tPA) bolus in eligible patients, time from initiation of CT scan to start of EVT, and hospital length of stay. In exploratory analysis, the study team evaluated the impact of AI implementation on 90-day modified Rankin Scale disability outcomes. RESULTS: Among 243 patients who met inclusion criteria, 140 were treated during the unexposed period and 103 during the exposed period. Median age for the complete cohort was 70 (IQR, 58-79) years and 122 were female (50%). Median National Institutes of Health Stroke Scale score at presentation was 17 (IQR, 11-22) and the median DTG preexposure was 100 (IQR, 81-116) minutes. In mixed-effects linear regression, implementation of the AI algorithm was associated with a reduction in DTG time by 11.2 minutes (95% CI, −18.22 to −4.2). Time from CT scan initiation to EVT start fell by 9.8 minutes (95% CI, −16.9 to −2.6). There were no differences in IV tPA treatment times nor hospital length of stay. In multivariable logistic regression adjusted for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early CT Score, there was no difference in likelihood of functional independence (modified Rankin Scale score, 0-2; odds ratio, 1.3; 95% CI, 0.42-4.0). CONCLUSIONS AND RELEVANCE: Automated LVO detection coupled with secure mobile phone application-based communication improved in-hospital acute ischemic stroke workflows. Software implementation was associated with clinically meaningful reductions in EVT treatment times. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05838456 American Medical Association 2023-09-18 2023-11 /pmc/articles/PMC10507590/ /pubmed/37721738 http://dx.doi.org/10.1001/jamaneurol.2023.3206 Text en Copyright 2023 Martinez-Gutierrez JC et al. JAMA Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Martinez-Gutierrez, Juan Carlos
Kim, Youngran
Salazar-Marioni, Sergio
Tariq, Muhammad Bilal
Abdelkhaleq, Rania
Niktabe, Arash
Ballekere, Anjan N.
Iyyangar, Ananya S.
Le, Mai
Azeem, Hussain
Miller, Charles C.
Tyson, Jon E.
Shaw, Sandi
Smith, Peri
Cowan, Mallory
Gonzales, Isabel
McCullough, Louise D.
Barreto, Andrew D.
Giancardo, Luca
Sheth, Sunil A.
Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial
title Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial
title_full Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial
title_fullStr Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial
title_full_unstemmed Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial
title_short Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial
title_sort automated large vessel occlusion detection software and thrombectomy treatment times: a cluster randomized clinical trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507590/
https://www.ncbi.nlm.nih.gov/pubmed/37721738
http://dx.doi.org/10.1001/jamaneurol.2023.3206
work_keys_str_mv AT martinezgutierrezjuancarlos automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT kimyoungran automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT salazarmarionisergio automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT tariqmuhammadbilal automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT abdelkhaleqrania automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT niktabearash automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT ballekereanjann automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT iyyangarananyas automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT lemai automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT azeemhussain automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT millercharlesc automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT tysonjone automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT shawsandi automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT smithperi automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT cowanmallory automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT gonzalesisabel automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT mcculloughlouised automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT barretoandrewd automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT giancardoluca automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial
AT shethsunila automatedlargevesselocclusiondetectionsoftwareandthrombectomytreatmenttimesaclusterrandomizedclinicaltrial